The start-up has dosed the first participant in a Phase I study with its lead candidate HRX-0215. The small molecule holds strong potential to restore the liver’s natural capacity to regenerate itself, both in acute and chronic liver disease.

Initiation of the IMAGE1NE Phase 1/2 clinical study of TK-8001, a TCR-T cell therapy for MAGE-A1 positive solid tumors, in Q4 2021

The HIOH pursues an integrative approach to understanding the emergence of new pathogens and developing suitable intervention mechanisms. Ascenion is its technology transfer partner.

Biomax Informatics AG, a well-established start-up from the Helmholtz Zentrum München, has been acquired by Horizonte Venture Management. The proceeds from the sale of Ascenion’s equity will be distributed as research grants via the LifeScience Foundation.

The Berlin start-up uses AI to recognize post-operative complications before they become critical. IBB Ventures and several business angels have invested in the company.

Scientists from the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Julius Maximilian University (JMU) in Würzburg have paved the way for a new diagnostic platform that enables the detection of multiple markers in one single test.

Join Europe's Knowledge Transfer community at the sector's premier annual event uniting experts, professionals, and industry from around the world. The new office ticket allows you to participate with the whole team for just 1,500 EUR.

BioVaria Startup Awards go to iRASP Therapeutics and OrganoTherapeutics

The current COVID-19 pandemic has drastically made us aware of how inadequate the present precautions are against infections transmitted by droplets…

Technology sneak peek from Ascenion: Seven breakthrough life-science inventions

16 partners from academia and industry will closely collaborate to prepare a future generation of scientists with outstanding skills in both machine learning and chemistry, to create new AI methods for drug research.

Ascenion, technology transfer partner of Hannover Medical School (MHH), has supported the conclusion of a collaboration and licence agreement between MHH and Novo Nordisk.

This year’s BioVaria is digital and takes place exclusively online from the 26 to 28 April 2021.

As part of its ‘GO-Bio initial’ programme, the BMBF has awarded Ascenion funding for its 'Life Science Digital Hub' concept to improve support for GO-Bio initial applicants.

Prague, Czech Republic

Ankara, Turkey

Cologne, Germany